Just a moment...
Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review. 
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether clinical samples of patent and proprietary medicines cleared under the exemption notification were "finished excisable goods" wholly exempted from excise duty so as to attract the proviso to Rule 56-A of the Central Excise Rules, 1944 and deny credit of duty on materials used in their manufacture.
Analysis: Rule 56-A permitted credit of duty on materials or component parts used in the manufacture of specified excisable goods, but the proviso withheld such credit where the finished excisable goods produced by the manufacturer were exempted from the whole of the excise duty leviable thereon. The notification for clinical samples granted exemption only up to a quantified limit linked to the manufacturer's clearances. The Court held that this was nonetheless a complete exemption for the identified quantity of clinical samples, and that the concession could not be treated as falling outside the proviso. The argument based on strict construction of the proviso did not assist the petitioners, because the notification still placed the relevant quantity of samples outside the excise levy.
Conclusion: The proviso to Rule 56-A applied, and the petitioners were not entitled to credit of duty on materials used for the exempt clinical samples.
Final Conclusion: The challenge to the excise demand failed, and the orders of the authorities were upheld.
Ratio Decidendi: Where finished goods or a defined quantity of such goods are wholly exempt from excise duty under a notification, the proviso to Rule 56-A of the Central Excise Rules, 1944 bars duty credit on materials used in their manufacture, even if the exemption operates as a concession or is quantity-limited.